Switch to:
More From Other Websites
Can Pfizer Boost Its Value By $5 Billion By Taking Over Bristol? Mar 27 2017
A.M. Best Affirms Credit Ratings of Blue Whale Re Ltd. Mar 27 2017
A.M. Best Affirms Credit Ratings of Blue Whale Re Ltd. Mar 27 2017
Pfizer Stock Rises on Bristol-Myers Takeover Talk Mar 27 2017
Pfizer Rheumatoid Arthritis Drug Approved in EU Mar 27 2017
Bristol-Myers: Maybe a Pfizer Acquisition Could Makes Sense After All? Mar 27 2017
5:04 am Pfizer receives Marketing Authorisation in the EU for XELJANZ Mar 27 2017
XELJANZ® (tofacitinib citrate) Receives Marketing Authorisation in the European Union for the... Mar 27 2017
XELJANZ® (tofacitinib citrate) Receives Marketing Authorisation in the European Union for the... Mar 27 2017
Large-Cap Stocks Mostly Lower With Health Care Vote Uncertainty Mar 24 2017
Trump, Ryan Spike Health Care Vote in Setback for President, GOP Mar 24 2017
Novartis’s Valuation Compared to Its Peers’ Mar 24 2017
Healthcare: Will They or Won't They? Mar 24 2017
Mylan Hit After Abbott Dumps Shares Mar 24 2017
Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval Mar 24 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK